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The Editor welcomes submissions for
possible publication in the Letters to the
Editor section that consist of commen-
tary on an article published in the Jour-
nal or other relevant issues. Authors
should:
● Include no more than 500 words of text,
three authors, and five references
● Type with double-spacing
● See http://jtcs.ctsnetjournals.org/misc/
ifora.shtml for detailed submission
instructions.
● Submit the letter electronically via
jtcvs.editorialmanager.com.
Letters commenting on an article pub-
lished in the JTCVS will be considered if
they are received within 6 weeks of the
time the article was published. Authors
of the article being commented on will be
given an opportunity to offer a timely
response (2 weeks) to the letter. Authors
of letters will be notified that the letter
has been received. Unpublished letters
cannot be returned.
Theply to the Editor:
e thank Rea, Marulli, and Sartori1 for
heir kind comments and insightful remarks
n the February 2007 issue of the Journal
oncerning our report on superior vena
ava (SVC) replacement with a heterolo-
ous (bovine) custom-made pericardial
rosthesis.2
SVC surgery is becoming an interesting
eld of study, particularly with reference to
ndications for this kind of surgery and to
esection and reconstruction techniques de-
ending on the degree of venous infiltration
nd the surgeon’s attitude.
Regarding the first point, we agree with
ea, Marulli, and Sartori about the indica-
ions for SVC surgery being very limited.
andidates’ selection for this kind of oper-
tion remains the main factor to obtain
ood surgical results. From our experi-
nce,3 these candidates should be less th
0 years old, with a predicted postoperative
orced expiratory volume in 1 second of
ore than 40%, no major cardiac comor-
idity, and an American Society of Anes-
hesiologists score of 1 or 2. From an on-
ologic point of view, patients with SVC
nvolvement should be carefully selected:
e have restricted surgical indications to
atients with T4 N0/N1 disease after induc-
ion chemotherapy.
Concerning technical aspects of SVC
urgery, we concur with Rea, Marulli, and
artori about the type of SVC resection. As
e3 recently reported in our single-cent
xperience with SVC surgery, we think
hat when vessel involvement is less than
0%, resection and direct repair (by tan-
ential clamping and simple running
olypropylene suture or vascular stapler) is
referred. When the SVC is not circumfer-
ntially resected, it may be crossclamped
nd repaired by an autologous pericardial
atch.
When SVC infiltration involves more
han 50% of the vessel circumference and a
ircumferential resection is performed, a
rosthetic replacement by a crossclamp
echnique is required. Even though w3
sed a synthetic prosthesis (polytetrafluo-
oethylene graft) in our earlier report, we
1
e Journal of Thoracic and Cardiovascular Save abandoned this material for SVC re-
onstruction owing to its high risk of
hrombosis.4 We concur with Rea, Marul
nd Sartori that autologous pericardium
epresents an ideal material for the recon-
truction of the SVC and we also congrat-
late them for their results in this very
ifficult group of patients.
Autologous pericardium has a number
f advantages (biocompatibility, adequate
esistance, cost free, availability), but it is
ifficult to handle. It shrinks and curls after
uturing and stretches after venous pressure
s restored, requiring trimming to the ap-
ropriate size. In addition, when a wide
ericardial resection is required for onco-
ogic reasons, the pericardium may be not
ufficient for the conduit reconstruction
nd the pericardial defect may cause post-
perative arrhythmias. Some authors5 have
reated autologous pericardium with glutar-
ldehyde to improve tissue stability and
reserve the pericardial patch, but that has
een shown to damage connective tissue,
redisposing tissue to mineralization.
For these reasons, since 2003 we have
dopted heterologous (bovine) pericardium
or constructing an SVC prosthesis. This
aterial has several advantages: it is fully
iocompatible and stiffer than autologous
ericardium, eliminating technical prob-
ems (shrinking and stretching), its patency
emains satisfactory over time, and it car-
ies a lower risk of infection and thrombo-
is.
In conclusion, we believe that the re-
lacement of the SVC by a bovine pericar-
ial conduit is an excellent solution in se-
ected cases, even if its efficacy should be
onfirmed by a large study.
Domenico Galetta, MDa
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